6.ALPHA.-FLUORO-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3,20-DIOXOPREGN-4-EN-21-YL 2,2-DIMETHYLPROPANOATE
UNII H2AW5J6WT8
Substance Identification & Data
This profile provides standardized clinical and technical data for 6.alpha.-fluoro-11.beta.-hydroxy-16.alpha.-methyl-3,20-dioxopregn-4-en-21-yl 2,2-dimethylpropanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H2AW5J6WT8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H39FO5 KCKYQYRLZLJKKC-HZMVJJPJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6.alpha.-fluoro-11.beta.-hydroxy-16.alpha.-methyl-3,20-dioxopregn-4-en-21-yl 2,2-dimethylpropanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.